I Programmi VEQ sono organizzati dal Centro Nazionale Sangue (CNS) in collaborazione con il Centro Nazionale per il Controllo e la Valutazione dei Farmaci (CNCF) dell’Istituto Superiore di Sanità (ISS).
Responsabili Scientifici e Coordinatori dei Programmi VEQ sono il Dott. Matteo Simeoni (biotecnologo, ricercatore, CNCF) e la Dott.ssa Ilaria Pati (biologa, responsabile del Settore Emovigilanza e Sorveglianza Epidemiologica dei donatori di sangue, CNS).
Se desideri ricevere maggiori informazioni sui Programmi VEQ, contattaci via e-mail agli indirizzi: matteo.simeoni@iss.it; ilaria.pati@iss.it; segreteriagenerale.cns@iss.it.
Who we are
EQA Programmes are organized by the National Blood Center (CNS) in collaboration with the National Centre for the Control and Evaluation of Medicines (CNCF) of the Istituto Superiore di Sanità (ISS).
The Scientific Directors of the EQA Programs are Dr. Matteo Simeoni (biotechnologist, researcher, CNCF) and Dr. Ilaria Pati (biologist, responsible of the Epidemiological Surveillance Sector for blood donors, CNS).
If you want to receive more information about EQA Programmes, please contact us by e-mail at the addresses: matteo.simeoni@iss.it; ilaria.pati@iss.it; segreteriagenerale.cns@iss.it.
Pubblicazioni/Publications
Pisani, F. Marino, K. Cristiano, et al. External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology:a novel approach Vox Sanguinis 2008, 95:8-12.
Gentili, G. Pisani, J. Saldanha, et al. High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology Vox Sanguinis 2003, 85: 114-116.
Pisani, K. Cristiano, M. Wirz, et al. Further evidence on the high proficiency of laboratories involved in plasma pool testing for HCV RNA by nucleic acid amplification technology Vox Sanguinis 2002, 82:211-212.
Gentili, G. Pisani, G. Bisso, et al. Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: external quality assessment Vox Sanguinis 2001, 81:143-147.